Literature DB >> 21402847

Susceptibility of 186 Nocardia sp. isolates to 20 antimicrobial agents.

Julián Larruskain1, Pedro Idigoras, José M Marimón, Emilio Pérez-Trallero.   

Abstract

This study determined the antimicrobial susceptibilities of 186 clinical isolates of Nocardia spp. isolated in Gipuzkoa, northern Spain, between 1998 and 2009. Most isolates were recovered from respiratory samples, Nocardia nova, N. farcinica, N. cyriacigeorgica, N. abscessus, and N. carnea being the species most frequently isolated. Linezolid and amikacin were the only two antimicrobials to which all isolates were susceptible. The majority of N. flavorosea, N. carnea, and N. farcinica isolates were trimethoprim-sulfamethoxazole resistant.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21402847      PMCID： PMC3101401          DOI： 10.1128/AAC.01279-10

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  14 in total

Review 1.  Nocardiosis: review of clinical and laboratory experience.

Authors:  Michael A Saubolle; Den Sussland
Journal:  J Clin Microbiol       Date:  2003-10       Impact factor: 5.948

2.  In vitro activity of ACH-702, a new isothiazoloquinolone, against Nocardia brasiliensis compared with econazole and the carbapenems imipenem and meropenem alone or in combination with clavulanic acid.

Authors:  Lucio Vera-Cabrera; Mayra Paola Campos-Rivera; Wendy G Escalante-Fuentes; Michael J Pucci; Jorge Ocampo-Candiani; Oliverio Welsh
Journal:  Antimicrob Agents Chemother       Date:  2010-03-22       Impact factor: 5.191

3.  Antimicrobial susceptibility patterns of Nocardia asteroides.

Authors:  R J Wallace; L C Steele; G Sumter; J M Smith
Journal:  Antimicrob Agents Chemother       Date:  1988-12       Impact factor: 5.191

4.  In vitro activities of tigecycline and eight other antimicrobials against different Nocardia species identified by molecular methods.

Authors:  Emilia Cercenado; Mercedes Marín; Mónica Sánchez-Martínez; Oscar Cuevas; José Martínez-Alarcón; Emilio Bouza
Journal:  Antimicrob Agents Chemother       Date:  2006-12-28       Impact factor: 5.191

5.  Clinical and microbiological features of nocardiosis 1997-2003.

Authors:  J Muñoz; B Mirelis; L M Aragón; N Gutiérrez; F Sánchez; M Español; O Esparcia; M Gurguí; P Domingo; P Coll
Journal:  J Med Microbiol       Date:  2007-04       Impact factor: 2.472

6.  Determination of antimicrobial susceptibility patterns of Nocardia spp. from clinical specimens by Etest.

Authors:  Y Glupczynski; C Berhin; M Janssens; G Wauters
Journal:  Clin Microbiol Infect       Date:  2006-09       Impact factor: 8.067

7.  Rapid identification of mycobacteria to the species level by polymerase chain reaction and restriction enzyme analysis.

Authors:  A Telenti; F Marchesi; M Balz; F Bally; E C Böttger; T Bodmer
Journal:  J Clin Microbiol       Date:  1993-02       Impact factor: 5.948

Review 8.  Infection caused by Nocardia farcinica: case report and review.

Authors:  O H Torres; P Domingo; R Pericas; P Boiron; J A Montiel; G Vázquez
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2000-03       Impact factor: 3.267

9.  Rapid identification of clinically significant species and taxa of aerobic actinomycetes, including Actinomadura, Gordona, Nocardia, Rhodococcus, Streptomyces, and Tsukamurella isolates, by DNA amplification and restriction endonuclease analysis.

Authors:  V A Steingrube; R W Wilson; B A Brown; K C Jost; Z Blacklock; J L Gibson; R J Wallace
Journal:  J Clin Microbiol       Date:  1997-04       Impact factor: 5.948

10.  Clinical and laboratory features of Nocardia nova.

Authors:  R J Wallace; B A Brown; M Tsukamura; J M Brown; G O Onyi
Journal:  J Clin Microbiol       Date:  1991-11       Impact factor: 5.948
View more
  43 in total

1.  First case of disseminated infection with Nocardia cerradoensis in a human.

Authors:  Caroline Piau; Mallorie Kerjouan; Marc Le Mouel; Solene Patrat-Delon; Pierre-Louis Henaux; Vanessa Brun; Marie-Pascale Morin; Philippe Gautier; Veronica Rodriguez-Nava; Samer Kayal
Journal:  J Clin Microbiol       Date:  2015-01-07       Impact factor: 5.948

2.  First report of Nocardia fusca isolated in humans.

Authors:  María Ercibengoa Arana; José María Marimón Ortiz de Zarate
Journal:  BMJ Case Rep       Date:  2015-06-02

Review 3.  Nocardiosis: A Neglected Disease.

Authors:  Shalini Dewan Duggal; Tulsi Das Chugh
Journal:  Med Princ Pract       Date:  2020-05-18       Impact factor: 1.927

4.  Antimicrobial susceptibility among clinical Nocardia species identified by multilocus sequence analysis.

Authors:  Lisa R McTaggart; Jennifer Doucet; Maria Witkowska; Susan E Richardson
Journal:  Antimicrob Agents Chemother       Date:  2014-10-27       Impact factor: 5.191

Review 5.  Nocardia infections among immunomodulated inflammatory bowel disease patients: A review.

Authors:  Cândida Abreu; Nuno Rocha-Pereira; António Sarmento; Fernando Magro
Journal:  World J Gastroenterol       Date:  2015-06-07       Impact factor: 5.742

6.  Rare case of osteomyelitis of tibial shaft caused by Nocardia cyriacigeorgica.

Authors:  D Raszka; S Popelka; J Heřt; D Jahoda; I Landor; P Vavřík
Journal:  Folia Microbiol (Praha)       Date:  2018-03-05       Impact factor: 2.099

7.  Sulfonamide resistance in isolates of Nocardia spp. from a US multicenter survey.

Authors:  Barbara A Brown-Elliott; Jon Biehle; Patricia S Conville; Samuel Cohen; Michael Saubolle; Den Sussland; Nancy Wengenack; Kimberly Kriel; Linda Bridge; Steven McNulty; Ravikiran Vasireddy; Richard J Wallace
Journal:  J Clin Microbiol       Date:  2011-12-14       Impact factor: 5.948

8.  Unusual presentation of disseminated Nocardia abscessus infection in a patient with AIDS.

Authors:  Jacqueline Sherbuk; Danielle Saly; Lydia Barakat; Onyema Ogbuagu
Journal:  BMJ Case Rep       Date:  2016-07-20

9.  Identification, typing, and phylogenetic relationships of the main clinical Nocardia species in spain according to their gyrB and rpoB genes.

Authors:  Gema Carrasco; Sylvia Valdezate; Noelia Garrido; Pilar Villalón; Maria J Medina-Pascual; Juan A Sáez-Nieto
Journal:  J Clin Microbiol       Date:  2013-08-21       Impact factor: 5.948

10.  Inhibition Activity of Avibactam against Nocardia farcinica β-Lactamase FARIFM10152.

Authors:  David Lebeaux; Clément Ourghanlian; Delphine Dorchène; Daria Soroka; Zainab Edoo; Fabrice Compain; Michel Arthur
Journal:  Antimicrob Agents Chemother       Date:  2020-01-27       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.